These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37861536)

  • 1. Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review.
    Goyal A; Zarroli K
    Medicine (Baltimore); 2023 Oct; 102(42):e35545. PubMed ID: 37861536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].
    Noda M; Sonoda Y; Takemoto M; Kira R
    No To Hattatsu; 2017 May; 49(3):207-10. PubMed ID: 30113799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetazolamide for the treatment of idiopathic intracranial hypertension.
    Supuran CT
    Expert Rev Neurother; 2015; 15(8):851-6. PubMed ID: 26154918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dural Venous Sinus Stenting in Idiopathic Intracranial Hypertension: A National Database Study of 541 Patients.
    Nia AM; Srinivasan VM; Lall R; Kan P
    World Neurosurg; 2022 Nov; 167():e451-e455. PubMed ID: 35973522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
    ; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
    JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for idiopathic intracranial hypertension.
    Piper RJ; Kalyvas AV; Young AM; Hughes MA; Jamjoom AA; Fouyas IP
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD003434. PubMed ID: 26250102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Resonance Imaging of Idiopathic Intracranial Hypertension: Before and After Treatment.
    Batur Caglayan HZ; Ucar M; Hasanreisoglu M; Nazliel B; Tokgoz N
    J Neuroophthalmol; 2019 Sep; 39(3):324-329. PubMed ID: 31430269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Idiopathic Intracranial Hypertension.
    Wall M
    Neurol Clin; 2017 Feb; 35(1):45-57. PubMed ID: 27886895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study.
    Adderley NJ; Subramanian A; Perrins M; Nirantharakumar K; Mollan SP; Sinclair AJ
    Neurology; 2022 Oct; 99(18):e1968-e1978. PubMed ID: 35985824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study.
    Celebisoy N; Gökçay F; Sirin H; Akyürekli O
    Acta Neurol Scand; 2007 Nov; 116(5):322-7. PubMed ID: 17922725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of idiopathic intracranial hypertension.
    Raoof N; Hoffmann J
    Cephalalgia; 2021 Apr; 41(4):472-478. PubMed ID: 33631966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of opening CSF pressure in response to treatment for idiopathic intracranial hypertension (IIH).
    Togha M; Martami F; Rahmanzadeh R; Ghorbani Z; Refaeian F; Behbahani S; Panahi P; Moghadam NB; Nafissi S; Shahbazi M
    J Clin Neurosci; 2020 Jun; 76():171-176. PubMed ID: 32331944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update of idiopathic intracranial hypertension.
    Madriz Peralta G; Cestari DM
    Curr Opin Ophthalmol; 2018 Nov; 29(6):495-502. PubMed ID: 30169466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial.
    Bruce BB; Digre KB; McDermott MP; Schron EB; Wall M;
    Neurology; 2016 Nov; 87(18):1871-1877. PubMed ID: 27694262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetazolamide-Induced Nephrolithiasis in Idiopathic Intracranial Hypertension Patients.
    Au JN; Waslo CS; McGwin G; Huisingh C; Tanne E
    J Neuroophthalmol; 2016 Jun; 36(2):126-30. PubMed ID: 26606175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic intracranial hypertension in two twin sisters.
    Jirapanyayut P; March de Ribot F; March de Ribot A
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38367985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dural Venous Sinus Stent Placement Reduces Dosage Requirements for Carbonic Anhydrase Inhibitors in Patients with Idiopathic Intracranial Hypertension.
    Martin J; Sanborn MR
    J Vasc Interv Radiol; 2023 Aug; 34(8):1359-1363. PubMed ID: 37030423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri.
    Cappuzzo JM; Hess RM; Morrison JF; Davies JM; Snyder KV; Levy EI; Siddiqui AH
    Neurosurg Focus; 2018 Jul; 45(1):E11. PubMed ID: 29961386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of idiopathic intracranial hypertension (IIH) in children and adolescents.
    Victorio MC; Rothner AD
    Curr Neurol Neurosci Rep; 2013 Mar; 13(3):336. PubMed ID: 23361857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.
    Smith SV; Friedman DI
    Headache; 2017 Sep; 57(8):1303-1310. PubMed ID: 28758206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.